Eprosartan (Teveten) offers new opportunities to prevent a second stroke.
D000179:Acrylates / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D009568:Nitrendipine / Q000627:therapeutic use; D020521:Stroke / Q000517:prevention & control*; D013876:Thiophenes / Q000627:therapeutic use*
D000179:Acrylates; D000959:Antihypertensive Agents; D007093:Imidazoles; D013876:Thiophenes; C068373:eprosartan; D009568:Nitrendipine